terfenadine has been researched along with B16 Melanoma in 1 studies
Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Onwuha-Ekpete, L | 1 |
| Tack, L | 1 |
| Knapinska, A | 1 |
| Smith, L | 1 |
| Kaushik, G | 1 |
| Lavoi, T | 1 |
| Giulianotti, M | 1 |
| Houghten, RA | 1 |
| Fields, GB | 1 |
| Minond, D | 1 |
1 other study available for terfenadine and B16 Melanoma
| Article | Year |
|---|---|
Novel pyrrolidine diketopiperazines selectively inhibit melanoma cells via induction of late-onset apoptosis.
Topics: Animals; Apoptosis; Melanoma, Experimental; Mice; Piperazines; Pyrrolidines | 2014 |